Aug 1 |
Regeneron: Q2 Earnings Snapshot
|
Aug 1 |
Regeneron Pharmaceuticals Non-GAAP EPS of $11.56 beats by $0.94, revenue of $3.55B beats by $160M
|
Aug 1 |
Regeneron Reports Second Quarter 2024 Financial and Operating Results
|
Jul 31 |
Regeneron Pharmaceuticals Q2 2024 Earnings Preview
|
Jul 31 |
Regeneron Announces the 2024 Winners of the Regeneron Prize for Creative Innovation
|
Jul 30 |
Watch These 5 Biotech Stocks for Q2 Earnings: Beat or Miss?
|
Jul 30 |
Exelixis (EXEL) Reports Next Week: Wall Street Expects Earnings Growth
|
Jul 30 |
Roche’s Vabysmo challenges Eylea dominance with third European indication
|
Jul 30 |
BioNTech posts mid-stage win for mRNA cancer drug with Regeneron’s Libtayo
|
Jul 30 |
The Zacks Analyst Blog Highlights Goldman Sachs, RTX, Regeneron and Optex Systems
|